• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲基强的松龙在脊髓损伤人群样本中的使用情况及疗效

Utilization and effectiveness of methylprednisolone in a population-based sample of spinal cord injured persons.

作者信息

Gerhart K A, Johnson R L, Menconi J, Hoffman R E, Lammertse D P

机构信息

Craig Hospital, Rocky Mountain Regional Spinal Injury System, Englewood, Colorado, USA.

出版信息

Paraplegia. 1995 Jun;33(6):316-21. doi: 10.1038/sc.1995.71.

DOI:10.1038/sc.1995.71
PMID:7644256
Abstract

The announcement and publication of the second National Acute Spinal Cord Injury Study (NASCIS II) project's findings regarding the role of high dose methylprednisolone in improving neurological outcomes following acute traumatic spinal cord injury generated widespread excitement and interest. To determine the association between this interest and actual use and implementation of the protocol, Colorado's comprehensive population-based spinal cord injury surveillance data were examined. The medical records of 218 SCI survivors injured between May 1, 1990 and December 31, 1991, and of 145 persons spinal cord injured 2 years later, during 1993, were reviewed to determine the rapidity and extent of NASCIS II implementation by Colorado's hospitals, factors associated with use and non-use of the protocol, changing usage trends over time, and the short term neurological outcomes of patients who received the protocol. Clear documentation of the protocol's usage was present for only 46% of the reported patients' medical records in 1990-91, and 61% in 1993. Small, emergency triage facilities were significantly more likely to use the protocol than larger acute care hospitals, and patients with initially incomplete injuries were less likely to receive the drug. There were no significant differences in neurological outcomes, using the Frankel classification system, between those who received the protocol and those who did not. The limitations and implications of these findings are discussed.

摘要

第二项全国急性脊髓损伤研究(NASCIS II)项目公布了关于大剂量甲基强的松龙在改善急性创伤性脊髓损伤后神经功能结果方面作用的研究结果,这引起了广泛的关注和兴趣。为了确定这种关注与该方案的实际使用和实施之间的关联,研究人员审查了科罗拉多州基于人群的全面脊髓损伤监测数据。研究人员查阅了1990年5月1日至1991年12月31日期间受伤的218名脊髓损伤幸存者以及1993年(即两年后)受伤的145人的医疗记录,以确定科罗拉多州医院实施NASCIS II的速度和程度、与该方案使用和未使用相关的因素、随时间变化的使用趋势,以及接受该方案治疗的患者的短期神经功能结果。在1990 - 1991年报告的患者医疗记录中,只有46%有该方案使用的明确记录,1993年这一比例为61%。小型急诊分诊机构比大型急性护理医院更有可能使用该方案,而最初损伤不完全的患者接受该药物治疗的可能性较小。使用Frankel分类系统,接受该方案治疗的患者和未接受该方案治疗的患者在神经功能结果方面没有显著差异。本文讨论了这些研究结果的局限性和意义。

相似文献

1
Utilization and effectiveness of methylprednisolone in a population-based sample of spinal cord injured persons.甲基强的松龙在脊髓损伤人群样本中的使用情况及疗效
Paraplegia. 1995 Jun;33(6):316-21. doi: 10.1038/sc.1995.71.
2
Use and determinants of the methylprednisolone protocol for traumatic spinal cord injury in South Carolina acute care hospitals.南卡罗来纳州急性护理医院中甲基强的松龙方案在创伤性脊髓损伤治疗中的应用及影响因素
J Trauma. 2009 May;66(5):1446-50; discussion 1450. doi: 10.1097/TA.0b013e318190bf49.
3
Changes in the use of the methylprednisolone protocol for traumatic spinal cord injury in Switzerland.瑞士外伤性脊髓损伤中甲基强的松龙方案使用的变化。
Spine (Phila Pa 1976). 2012 May 15;37(11):953-6. doi: 10.1097/BRS.0b013e31823a07a2.
4
[Current role of methylprednisolone in the treatment of acute spinal cord injury].[甲泼尼龙在急性脊髓损伤治疗中的当前作用]
Acta Chir Orthop Traumatol Cech. 2011;78(4):305-13.
5
Methylprednisolone after spinal cord injury.脊髓损伤后的甲基强的松龙
SCI Nurs. 1993 Mar;10(1):8-14.
6
Administration of corticosteroids for acute spinal cord injury: the current practice of trauma medical directors and emergency medical system physician advisors.急性脊髓损伤的皮质类固醇给药:创伤医疗主任和紧急医疗系统医师顾问的当前实践
Spine (Phila Pa 1976). 2003 May 1;28(9):941-7; discussion 947. doi: 10.1097/01.BRS.0000058708.46933.3D.
7
The effect of methylprednisolone, naloxone, and spinal cord trauma on four liver enzymes: observations from NASCIS 2. National Acute Spinal Cord Injury Study.甲基强的松龙、纳洛酮及脊髓损伤对四种肝酶的影响:美国国立急性脊髓损伤研究(NASCIS 2)的观察结果
Paraplegia. 1994 Apr;32(4):236-45. doi: 10.1038/sc.1994.43.
8
The Second National Acute Spinal Cord Injury Study.第二次全国急性脊髓损伤研究
J Neurotrauma. 1992 Mar;9 Suppl 1:S397-405.
9
A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study.一项关于甲基泼尼松龙或纳洛酮治疗急性脊髓损伤的随机对照试验。第二次全国急性脊髓损伤研究结果。
N Engl J Med. 1990 May 17;322(20):1405-11. doi: 10.1056/NEJM199005173222001.
10
Pitfalls in treatment of acute cervical spinal cord injury using high-dose methylprednisolone: a retrospect audit of 111 patients.大剂量甲基强的松龙治疗急性颈髓损伤的陷阱:111例患者的回顾性审计
Surg Neurol. 2007;68 Suppl 1:S37-41; discussion S41-2. doi: 10.1016/j.surneu.2007.06.085.

引用本文的文献

1
Methylprednisolone for the Treatment of Patients with Acute Spinal Cord Injuries: A Systematic Review and Meta-Analysis.甲基强的松龙治疗急性脊髓损伤患者:系统评价与荟萃分析
J Neurotrauma. 2016 Mar 1;33(5):468-81. doi: 10.1089/neu.2015.4192. Epub 2015 Dec 15.
2
A review: the role of high dose methylprednisolone in spinal cord trauma in children.综述:大剂量甲泼尼龙在儿童脊髓损伤中的作用
Pediatr Surg Int. 2012 Mar;28(3):287-94. doi: 10.1007/s00383-011-3012-3. Epub 2011 Oct 13.
3
High dose methylprednisolone in the immediate management of acute, blunt spinal cord injury: what is the current practice in emergency departments, spinal units, and neurosurgical units in the UK?
大剂量甲泼尼龙在急性钝性脊髓损伤即刻处理中的应用:英国急诊科、脊髓治疗科室及神经外科科室的当前做法是什么?
Emerg Med J. 2006 Jul;23(7):550-3. doi: 10.1136/emj.2005.032698.
4
Continuous brain-derived neurotrophic factor (BDNF) infusion after methylprednisolone treatment in severe spinal cord injury.甲基强的松龙治疗严重脊髓损伤后持续输注脑源性神经营养因子(BDNF)
J Korean Med Sci. 2004 Feb;19(1):113-22. doi: 10.3346/jkms.2004.19.1.113.
5
New drugs for improving injury outcome in spinal cord injuries.用于改善脊髓损伤损伤结局的新药。
West J Med. 1997 Apr;166(4):271-2.